News

Milano (Italy), February 12th, 2020. AurorA-TT, Rottapharm Biotech and Italfarmaco announced today the inception of AurorA Science, an investment vehiclefocused on independent and entrepreneurial biotech start-ups with high therapeuticpotential. For the incorporation of AurorA Science, AurorA-TT has partnered with two strategic industrial investors, Rottapharm Biotech and Italfarmaco,...

For the first time in Italy, scientific research aligns into a common strategy to foster the birth of a Venture Capital fund fully dedicated to biotechnology. Milan (Italy), November 6th, 2017. In May 2017, AurorA-TT announced the launch of a Venture Capital fund fully dedicated to biotechnology...

Milan (Italy), May 18th, 2017. AurorA-TT recognizes a tremendous potential in the Italian research arena that however lacks an appropriate value creation and translation into care opportunities. AurorA-TT, therefore, intends to focus on Technology Transfer to exploit research potentials of academic and research institutions in...